IRMA AGUIRRE: Open Payments
NPI 1952851560 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 44 payments from 9 companies in 2025. Trend: 2023 $240 · 2024 $988 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $243 |
| ABBVIE INC. | 15 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| Aimmune Therapeutics, Inc. | 5 | $100 |
| Ipsen Biopharmaceuticals, Inc | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 5 | $63 |
| Ardelyx, Inc. | 3 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Novo Nordisk Inc | 1 | $15 |
Products named: DUPIXENT, RINVOQ, IQIRVO, ZENPEP, ENTYVIO, VOQUEZNA, CREON, IBSRELA.
Industry payments across TX — which companies pay providers there.
